Melanoma News Today

    Skip to content
    • Home
    • About Melanoma
    • Keytruda (Pembrolizumab)
    • Melanoma Clinical Trials
    • Contact Us
    January 10, 2017

    Experimental Compound Has Great Potential to Prevent Melanoma Metastases

    News
    Researchers have identified a compound that could prevent malignant melanoma cells from spreading throughout the body. If the compound is successfully developed into a human drug, it has the potential ... Read more
    January 3, 2017

    X Chromosome Study Explores Why Melanoma is More Deadly for Men

    News
    Men who develop melanoma are twice as likely to die from the disease as women, but the molecular mechanisms involved in such disparity remain largely unknown. Now, researchers have pinpointed ... Read more
    December 22, 2016

    Partners Should Be Trained to Check for Mole Irregularities

    News
    A new study from Northwestern Medicine shows the advantages of partners frequently checking for potentially dangerous moles, after receiving training to do so. The study, “Self-confidence and Embarrassment About Partner-Assisted Skin ... Read more
    December 20, 2016

    Treatment Blocking Melanoma Metastasis May Be on the Horizon

    News
    A treatment preventing cancer metastases may become a reality within a decade, as researchers pinpointed a molecule driving metastasis formation in several cancers, including malignant melanoma. But the findings also ... Read more
    December 15, 2016

    P15 Protein Levels Could Help Doctors Distinguish Melanoma from Benign Moles

    News
    Researchers have found that a protein, called p15, may be used as a biomarker to distinguish melanoma from nevi (non-cancerous moles in the skin). Loss of this protein, which inhibits nevus ... Read more
    December 13, 2016December 13, 2016

    Researchers Link Alcohol Consumption to Risk of Developing Invasive Melanoma

    News
    Alcohol consumption is associated with a moderate increase in the risk of developing melanoma, according to the findings of a recent study published in the Cancer Epidemiology, Biomarkers & Prevention, a ... Read more
    December 2, 2016

    Melanoma’s Signature, Disease Development Controlled by CPEB4 Protein, Study Finds

    News
    Researchers have identified a protein called CPEB4 that seems to be crucial in establishing melanoma’s intrinsic signature and in driving the development of these aggressive tumors. The study, “Lineage-specific roles ... Read more
    November 29, 2016November 29, 2016

    Virtual Clinical Trial Model Seen to Predict Real Responses of Melanoma Patients to Therapies

    News
    Researchers with Moffitt Cancer Center developed a computational framework that, they say, can accurately predict patient responses  to cancer treatments in a virtual clinical trial, called phase i. This new methodology integrates actual patient ... Read more
    November 17, 2016November 19, 2016

    Risk Factors for Melanoma May Influence When and Where Disease Strikes

    News
    A person’s risk factors for melanoma could be used to tailor surveillance programs and skin self-examinations for those at particular risk, according to a recent study published in JAMA Dermatology. The study, “Clinical Features ... Read more
    November 15, 2016November 19, 2016

    Diverse Gut Flora Associated with Better Immunotherapy Responses in Melanoma Patients

    News
    A new research study has found that malignant melanoma patients responded better to immunotherapy treatment when they had more diverse gut flora – microbes and bacteria that live in our ... Read more
    November 10, 2016November 10, 2016

    Therapy Combination Looks Promising to Treat BRAF-mutant Melanoma Patients

    News
    Combining the investigational drugs encorafenib and binimetinib to treat advanced melanoma patients provides better progression-free survival and overall response rates than Zelboraf (vemurafenib) monotherapy, according to recent data. The information was presented ... Read more
    November 8, 2016November 10, 2016

    Immunotherapy Seen as Optimal First-Line Treatment for Advanced Melanoma

    News
    Patients diagnosed in the late stages of melanoma who have BRAF mutations should be given immunotherapy as a first-line treatment, according to a systematic review published in JAMA Oncology. The study, “Systemic ... Read more
    November 6, 2016December 6, 2016

    Immunotherapies Should Be First-Line Treatment of High-risk Melanomas, Study Says

    News
    Patients with advanced melanoma have improved survival rates with superior safety when treated with protocols that combine immunotherapy options, researchers recommended. The study, “Systemic Therapy for Previously Untreated Advanced BRAF-Mutated Melanoma: ... Read more
    November 3, 2016

    Specialized Melanoma Surveillance Provides Better Outcomes, Lower Costs than Standard of Care, Study Finds

    News
    Clinical guidelines recommend that people at high risk for melanoma receive regular surveillance to improve survival through early cancer detection. In a recent Australian study, researchers have shown that monitoring ... Read more
    November 1, 2016November 1, 2016

    Promising Clinical Data from Melanoma Combination Therapy to Be Presented at Upcoming Meeting

    News
    Array BioPharma and Pierre Fabre will present data from the COLUMBUS Phase 3 clinical trial showing that melanoma patients with BRAF mutations may benefit more from the combination of encorafenib and ... Read more
    October 27, 2016

    Nearly One-Third of Metastatic Melanoma Patients in Europe Can’t Access Best Therapies for Survival, Survey Shows

    News
    Despite the advances in innovative targeted therapies and immunotherapies that largely increase melanoma survival rates, nearly one-third of metastatic melanoma patients in Europe are denied access to those new medicines. ... Read more
    October 25, 2016October 25, 2016

    Success of Melanoma Immunotherapy Boosted by Cells Grown in Antioxidant, Study Finds

    News
    Adoptive cell transfer — a type of immunotherapy when a patient’s own T-cells are harvested, genetically modified, and expanded in the lab — is much more efficient in melanoma if researchers make a ... Read more
    October 20, 2016May 29, 2017

    Keytruda and Yervoy Combo Shows Strong Activity in Advanced Melanoma Study

    News
    Combining two immunotherapies that block distinct immune checkpoints may be a promising approach for patients with advanced melanoma. According to data from a Phase 1/2 study, the Keytruda (pembrolizumab) plus Yervoy (ipilimumab) combination ... Read more
    October 18, 2016October 18, 2016

    New Psychological Intervention Eases Fears of Melanoma Recurrence

    News
    A new psychological intervention developed by a team of researchers based at Australia’s University of New South Wales, The University of Sydney, and the Melanoma Institute Australia, in partnership with ... Read more
    October 13, 2016

    Combo Therapy for Advanced Melanoma, Tafinlar and Mekinist, Seen to Improve 3-Year Survival

    News
    Combination treatment with Novartis‘ Tafinlar (dabrafenib) and Mekinist (trametinib) improved survival of advanced myeloma patients at three years, compared to patients treated with a BRAF blocker. These findings emerged as ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another melanoma update.

    * indicates required

    Recent Melanoma Articles

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • nevus mole prognosis BGB324

      New Clinical Trial Underway for Treatment of Advanced Melanoma

      May 25, 2017

    You May Also Like…..

    Opdivo, Yervoy Combo Improved Survival in Advanced Melanoma Phase 3 Trial

    April 6, 2017

    Opdivo, Yervoy combination

    Researchers Link Alcohol Consumption to Risk of Developing Invasive Melanoma

    December 13, 2016

    Alcohol consumption and melanoma

    Expert Panel Recommends National Guidelines to Improve Melanoma Screening

    March 28, 2017

    melanoma screening guidelines
    Visit Melanoma News Today's profile on Pinterest.
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • About Melanoma News Today
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Melanoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.